PharmacoScanTM is an ideal genotyping platform for translational researchers in pharma and research organizations looking to understand how genetic variations affect drug absorption, distribution, metabolism, and excretion (ADME).
We can precisely and reproducibly analyze 4,627 biomarkers within nearly 1,200 genes.
The solution includes detecting copy number variation (CNV) and interrogating predictive markers in complex genes (e.g. CYP2D6).
Unlike other platforms that analyze only high-evidence markers, our comprehensive testing approach presents a more complete view for genotyping for more accurate PGx risk evaluation.